首页 | 本学科首页   官方微博 | 高级检索  
检索        

我国原料药频遭印度反倾销的原因及对策分析
引用本文:唐亚军,董丽.我国原料药频遭印度反倾销的原因及对策分析[J].中国药事,2009,23(12):1176-1178.
作者姓名:唐亚军  董丽
作者单位:沈阳药科大学工商管理学院,沈阳,110016
摘    要:目的分析探讨我国原料药企业频繁遭到印度反倾销的原因及应对策略。方法分析近几年印度对我国原料药发起反倾销的情况,总结印度对我国原料药出口反倾销的原因,并针对我国原料药企业的现状提出对策。结果与结论我国企业既要提高应对能力,又要加强自身产业的发展,从内外两方面来应对印度对我国原料药的反倾销。

关 键 词:反倾销  原料药  印度

The Analysis of the Reasons for India's Anti-dumping to Chinese Bulk Drug Frequently and Our Countermeasures
Tang Yajun,Dong Li.The Analysis of the Reasons for India's Anti-dumping to Chinese Bulk Drug Frequently and Our Countermeasures[J].Chinese Pharmaceutical Affairs,2009,23(12):1176-1178.
Authors:Tang Yajun  Dong Li
Institution:(College of Business Administration,Shenyang Pharmaceutical University,Shenyang,110016)
Abstract:Objective To give the discussion and analysis of the reasons for India's anti-dumping to Chinese bulk drug frequently and our Countermeasures.Methods Analysis the anti-dumping cases that India have launched to the Chinese bulk drug,Summed up the reasons that why India's anti-dumping to Chinese bulk drug frequently,come up with strategies and countermeasures to the status quo of our bulk drug companies.Results and Conclusions When we response to the anti-dumping case that India have launched to the Chinese bulk drug,Chinese enterprises should not only improve the ability to deal with,but also strengthen their own industries,From both inside and outside to deal with India's anti-dumping to Chinese bulk drug.
Keywords:anti-dumping bulk drug India
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号